Ana Marin-Niebla

8PUBLICATIONS
54CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematological tumoursImmunology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 22, 2025
Impact of SARS-CoV-2 infection on bispecific antibody treatment in patients with B-cell lymphoproliferative disorders.

Ángel Serna, Víctor Navarro, Moraima Jiménez

|Aug 16, 2022
A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression.

Pau Abrisqueta, Daniel Medina, Guillermo Villacampa

|Feb 25, 2022
Regulation of B-Cell Receptor Signaling and Its Therapeutic Relevance in Aggressive B-Cell Lymphomas.

Núria Profitós-Pelejà, Juliana Carvalho Santos, Ana Marín-Niebla

|Feb 07, 2022
Variant t(11;22)(q13;q11.2) with IGL involvement in mantle cell lymphoma.

Alba Cabirta, Gloria Hidalgo-Gómez, Ana Marín-Niebla

|Jan 14, 2022
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial.

Eva Giné, Fátima de la Cruz, Ana Jiménez Ubieto

|Nov 29, 2021
Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies.

Moraima Jiménez, Elisa Roldán, Candela Fernández-Naval

Pageof 2

Frequent Collaborators

3 joint publications

Marta Crespo

2 joint publications

Carlo Visco

2 joint publications

Francesca Maria Quaglia

2 joint publications

Stefan Hohaus